Hard to Treat Diseases
Hard to Treat Diseases HTDS Confirms the first Chilean order of 200,000 doses
Published in Vaccine Weekly, December 30th, 2009
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its China subsidiary Mellow Hope announce further update on the announcement of November 19, 2009 titled - "Hard To Treat Diseases (HTDS) Chilean first order of 200,000 doses - worth approximately $1.8 million USD" and the first shipment of H1N1 vaccine (Split Virion, Inactivated) shipment for Chile. The company is pleased to report that the first shipment or "put" has been completed. Regulatory government permission to release the goods is the next step however this has no impact on HTDS.
HTDS' negotiations with the Chilean ISP (Ministry of Health) bore the first fruits. The Chilean government purchased the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-12-30)
More Articles from Vaccine Weekly
- Rockefeller University Press
Hindering HIV-1-fighting immune cells - Thomas Jefferson University
Research reveals further progress toward AIDS vaccine - Adenovirus
Reports summarize adenovirus research from Vrije University Amsterdam - Bristol-Myers Squibb Company and Pfizer
Bristol-Myers Squibb and Pfizer Announce Plans To Submit Regulatory Filing for Apixaban In Europe - Candidiasis
New candidiasis data have been reported by researchers at University of Sao Paulo - Immunization
Research from University of Alabama provide new insights into immunization - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
